Durable Clinical Outcomes With Alemtuzumab in Patients With Active RRMS in the Absence of Continuous Treatment: 7-Year Follow-up of CARE-MS II Patients (TOPAZ Study)Barry A. Singer,Raed Alroughani,David Brassat,Simon Broadley,Hans-Peter Hartung,Eva Havrdova,Ho Jin Kim,Celia Oreja-Guevara,Carlo Pozzilli,Krzysztof W. Selmaj,Patrick Vermersch,Sibyl Wray,David H. Margolin,Luke Chung,Nadia Daizadeh,Madalina Chirieac,Alasdair J. ColesNEUROLOGY（2018）引用 2|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
